OPTINEX Trademark

Trademark Overview

On Tuesday, June 19, 2007, a trademark application was filed for OPTINEX with the United States Patent and Trademark Office. The USPTO has given the OPTINEX trademark a serial number of 77209293. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2011. This trademark is owned by Glaxo Group Limited. The OPTINEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines
optinex

General Information

Serial Number77209293
Word MarkOPTINEX
Filing DateTuesday, June 19, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 22, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 7, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 7, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 20, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 19, 2010EXTENSION 5 GRANTED
Monday, July 12, 2010EXTENSION 5 FILED
Monday, July 12, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 30, 2010EXTENSION 4 GRANTED
Thursday, January 21, 2010EXTENSION 4 FILED
Thursday, January 21, 2010TEAS EXTENSION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 31, 2009EXTENSION 3 GRANTED
Thursday, July 30, 2009EXTENSION 3 FILED
Thursday, August 27, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 30, 2009TEAS EXTENSION RECEIVED
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 18, 2008EXTENSION 2 GRANTED
Thursday, December 18, 2008EXTENSION 2 FILED
Thursday, December 18, 2008TEAS EXTENSION RECEIVED
Wednesday, December 17, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 17, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 10, 2008EXTENSION 1 GRANTED
Thursday, July 10, 2008EXTENSION 1 FILED
Thursday, July 10, 2008TEAS EXTENSION RECEIVED
Thursday, July 10, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 5, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2007NOTICE OF PUBLICATION
Tuesday, October 9, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 9, 2007ASSIGNED TO LIE
Sunday, September 9, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, September 9, 2007ASSIGNED TO EXAMINER
Friday, June 22, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

optinex treatment disorders diseases respiratory neurological gastrointestinal dysfunction ophthalmological hepatological hormonal